Literature DB >> 21252862

NOS3 variants, physical activity, and blood pressure in the European Youth Heart Study.

Anders Grøntved1, Lars B Andersen, Paul W Franks, Bas Verhage, Nicholas J Wareham, Ulf Ekelund, Ruth J F Loos, Søren Brage.   

Abstract

BACKGROUND: In this study, we examined the influence of genetic variation in NOS3 on resting blood pressure (BP) in children and adolescents from the European Youth Heart Study (EYHS). Because the NOS3 gene expression is altered by physical activity (PA), we also tested for interaction between habitual PA and NOS3 variants on BP.
METHODS: A cross-sectional, random sample of 8-10-year old children (n = 1,214) and 14-16-year old adolescents (n = 1,141) from Denmark and Estonia were genotyped for four NOS3 tagging polymorphisms (rs1800783, rs1799983 (Glu298Asp), rs3918227, rs743507). PA was measured objectively using a hip-mounted accelerometer and through self-reported bicycling and TV-viewing. Permutation testing was used to correct for multiple testing, yielding an α level of 0.006.
RESULTS: Glu298Asp showed age-group-dependent associations with BP. In adolescents, Asp298 allele homozygotes had 0.19 s.d. (95% confidence interval (CI): 0.06; 0.13, P = 0.004) higher diastolic BP (DBP) and 0.25 s.d. (95% CI: 0.05; 0.46, P = 0.015) higher systolic BP (SBP), compared to Glu298 allele carriers. None of the three other single-nucleotide polymorphisms (SNPs) were associated with BP in adolescents. In children, none of the SNPs were associated with BP. No evidence of interaction between Glu298Asp and objectively measured PA was observed. Both self-reported bicycling and TV-viewing nominally modified the association between Glu298Asp and BP in adolescents (P < 0.05), the genetic effect being most apparent in inactive individuals. However, none of the interactions persisted after correcting for multiple testing.
CONCLUSIONS: The NOS3 Glu298Asp variant may associate with resting BP in adolescence but not in childhood, an effect that could be modified by PA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252862     DOI: 10.1038/ajh.2010.265

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  4 in total

Review 1.  Advances in exercise, fitness, and performance genomics in 2011.

Authors:  Stephen M Roth; Tuomo Rankinen; James M Hagberg; Ruth J F Loos; Louis Pérusse; Mark A Sarzynski; Bernd Wolfarth; Claude Bouchard
Journal:  Med Sci Sports Exerc       Date:  2012-05       Impact factor: 5.411

2.  Association of NOS3 tag polymorphisms with hypoxic-ischemic encephalopathy.

Authors:  Radenka Kuzmanić Samija; Dragan Primorac; Biserka Resić; Bernarda Lozić; Vjekoslav Krzelj; Maja Tomasović; Eugenio Stoini; Ljubo Samanović; Benjamin Benzon; Marina Pehlić; Vesna Boraska; Tatijana Zemunik
Journal:  Croat Med J       Date:  2011-06       Impact factor: 1.351

3.  Associations of the eNOS G894T gene polymorphism with target organ damage in children with newly diagnosed primary hypertension.

Authors:  Joanna Śladowska-Kozłowska; Mieczysław Litwin; Anna Niemirska; Aldona Wierzbicka; Marta Roszczynko; Małgorzata Szperl
Journal:  Pediatr Nephrol       Date:  2015-08-01       Impact factor: 3.714

4.  Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients.

Authors:  Julio D Duarte; Mayank Kansal; Ankit A Desai; Katherine Riden; Meghan J Arwood; Alex A Yacob; Thomas D Stamos; Larisa H Cavallari; Roham T Zamanian; Sanjiv J Shah; Roberto F Machado
Journal:  Pulm Circ       Date:  2018 Apr-Jun       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.